Markets:

Overview

News

Currencies

International

Treasuries

Vir Biotechnology, Inc. - Common Stock (NQ:VIR)

6.440 +0.320 (+5.23%)

Streaming Delayed Price Updated: 4:00 PM EST, Nov 25, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Vir Biotechnology, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

14 15 Next >

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

July 20, 2023

Via Benzinga

Why Infosys Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

July 20, 2023

Gainers PainReform Ltd. (NASDAQ: PRFX) jumped 45.5% to $10.34 after declining 8% on Wednesday. PaiReform recently regained compliance with Nasdaq continued listing requirements.

Via Benzinga

Dow On Track For 9 Straight After Johnson & Johnson Earnings ↗

July 20, 2023

The Dow Jones Industrial Average is looking to extend its win streak, last seen up 250 points as it paces for its ninth consecutive win.

Via Talk Markets

Why Vir Biotechnology Stock Is Plunging Today? ↗

July 20, 2023

Vir Biotechnology Inc (NASDAQ: VIR) shares are tumbling after the company released data from the Phase 2 PENINSULA evaluating VIR-2482 to prevent

Via Benzinga

What 8 Analyst Ratings Have To Say About Vir Biotechnology ↗

April 04, 2023

Via Benzinga

Dow Surges 300 Points; Johnson & Johnson Posts Upbeat Earnings ↗

July 20, 2023

U.S. stocks traded mixed midway through trading, with the Nasdaq Composite declining over 1% on Thursday. The Dow traded up 0.87% to 35,365.00 while the NASDAQ fell 1.11% to 14,198.86. The S&P 500,...

Via Benzinga

Why Shares of Vir Biotechnology Are Plunging Thursday ↗

July 20, 2023

The company had disappointing trial news for one of its lead therapies.

Via The Motley Fool

Nasdaq Down 50 Points; Tesla Earnings Beat Expectations ↗

July 20, 2023

U.S. stocks traded mixed this morning, with the Dow Jones gaining over 100 points on Thursday. Following the market opening Thursday, the Dow traded up 0.40% to 35,202.41 while the NASDAQ fell 0.35% to...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

July 20, 2023

Via Benzinga

Vir Biotechnology Announces Topline Data from Phase 2 PENINSULA Trial Evaluating VIR-2482 for the Prevention of Seasonal Influenza A Illness

July 20, 2023

From Vir Biotechnology, Inc.

Via GlobeNewswire

Vir Biotechnology Appoints Sasha Damouni Ellis as Executive Vice President and Chief Corporate Affairs Officer

June 29, 2023

From Vir Biotechnology, Inc.

Via GlobeNewswire

Post-COVID-19: How the COVAX Initiative Could Redirect its $2.6B Surplus to Fight Future Pandemics ↗

June 26, 2023

As the emergency phase of the COVID-19 pandemic draws to a close, the COVAX initiative, run by Gavi, the WHO, and CEPI, reportedly has $2.6 billion left over that could be used to prepare for other...

Via Benzinga

Vir Biotechnology Presents New Data Evaluating the Potential for VIR-2218 and VIR-3434 as Therapies for Chronic Hepatitis B and Hepatitis D

June 24, 2023

From Vir Biotechnology, Inc.

Via GlobeNewswire

Vir Biotechnology Announces Multiple Abstracts Highlighting New Hepatitis B and D Data Accepted for Presentation at EASL™ Congress 2023

June 07, 2023

– Data support the potential impact of VIR-2218 and VIR-3434 in addressing both HBV and HDV and underscore the Company’s confidence in its approach to a functional cure for HBV –

From Vir Biotechnology, Inc.

Via GlobeNewswire

Vir Biotechnology to Participate in the 44th Annual Goldman Sachs Global Healthcare Conference

June 05, 2023

From Vir Biotechnology, Inc.

Via GlobeNewswire

WHO Recommends New COVID Booster Shots To Target XBB Variants, Despite Slower Uptake ↗

May 19, 2023

An advisory group for the World Health Organization said the current crop of shots should be updated to target the currently dominant XBB strains for the

Via Benzinga

Vir Biotechnology to Host a Virtual-Only 2023 Annual Meeting of Stockholders

May 17, 2023

From Vir Biotechnology, Inc.

Via GlobeNewswire

Vir Biotechnology Appoints Jeff Calcagno, M.D., as Executive Vice President and Chief Business Officer

May 15, 2023

From Vir Biotechnology, Inc.

Via GlobeNewswire

Vir Biotechnology Announces First Patient Dosed in New Phase 2 Chronic Hepatitis B Virus Trial Evaluating Combinations of VIR-2218, VIR-3434, PEG-IFNα and an NRTI

May 11, 2023

From Vir Biotechnology, Inc.

Via GlobeNewswire

7 Top-Rated Stocks That Will Boost Your Portfolio in 2023 ↗

May 10, 2023

For those seeking to rise above the muck in a big way, these top-rated stocks to buy might accomplish just that.

Via InvestorPlace

WHO Ends Global Emergency Status for COVID-19 3 Years After Declaration, CDC Director Resigns ↗

May 08, 2023

The World Health Organization ended the global emergency

Via Benzinga

The 7 Best Bargain Stocks to Buy for May 2023 ↗

May 04, 2023

With inflation crimping everyone’s wallet, these best bargain stocks to buy can make your dollars stretch significantly.

Via InvestorPlace

Vir Biotechnology Provides Corporate Update and Reports First Quarter 2023 Financial Results

May 04, 2023

From Vir Biotechnology, Inc.

Via GlobeNewswire

Vir Biotechnology to Participate in the BofA Securities 2023 Health Care Conference

May 03, 2023

From Vir Biotechnology, Inc.

Via GlobeNewswire

Vir Biotechnology Receives Expanded Support to Develop Its Novel T Cell Vaccine Platform with New $10 Million Grant for HIV Prevention

May 02, 2023

From Vir Biotechnology, Inc.

Via GlobeNewswire

Why Shares of Keros Therapeutics Jumped This Week ↗

April 21, 2023

The company appointed a new director and an analyst reiterated his position on the stock.

Via The Motley Fool

Vir Biotechnology to Participate in the 22nd Annual Needham Virtual Healthcare Conference

April 11, 2023

From Vir Biotechnology, Inc.

Via GlobeNewswire

Biden Administration Launches $5B Program To Boost Development Of Pan-Coronavirus Vaccine, Treatments ↗

April 11, 2023

The White House plans to devote $5 billion to develop effective treatments and vaccines against current and future Covid variants, a Department of Health and Human Services (HHS) spokesperson and a...

Via Benzinga

7 Thrilling Biotech Stocks for Aggressive Investors to Buy ↗

April 05, 2023

Amid the noise of the global markets recently, these speculative biotech stocks to buy might trade with a mind of their own.

Via InvestorPlace

Where Did COVID-19 Really Originate? Biden Signs Bill To Declassify Origins Information ↗

March 21, 2023

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9

...

14 15 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Vir Biotechnology, Inc. - Common Stock (NQ:VIR)

All News about Vir Biotechnology, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today